Literature DB >> 13428929

Agglutinating efficiency and combining capacity of Shigella and Vibrio antisera from rabbits at different stages of immunization.

R FRETER.   

Abstract

Studies of the relative combining capacities of different antisera to Vibrio cholerae and Shigella flexneri were carried out using the Talmage test. In this test the absorption of an I(131) labelled antibody preparation by antigen is blocked by the addition of unlabelled unknown serum. Sera from rabbits in the early stages of immunization ("early antisera") had a high agglutinin titer, but low combining capacity. Sera from hyperimmune rabbits ("late antisera") had higher combining capacities than early antisera, but similar or lower agglutinin titers. More antigen was needed to absorb the agglutinins from late antisera than from early ones of the same agglutinin titer, indicating that late antisera contained relatively more antibody. At high concentrations, sera from hyperimmune rabbits agglutinated the homologous antigen more rapidly than did early antisera, even though early sera had similar or higher agglutinin titers. Sera drawn after the anamnestic response to bacterial antigen had the characteristics of late sera; i.e., their combining capacities were high. The possible significance of these findings for the in vitro estimation of protective antibody is discussed.

Entities:  

Keywords:  SHIGELLA/immunology; VIBRIO/immunology

Mesh:

Substances:

Year:  1957        PMID: 13428929      PMCID: PMC2136711          DOI: 10.1084/jem.105.6.623

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  The blocking of labeled antibody uptake as a measure of the relative combining capacity of anti-red cell serums.

Authors:  D W TALMAGE; G G FRETER
Journal:  J Infect Dis       Date:  1956 May-Jun       Impact factor: 5.226

2.  Two antibodies of related specificity but different hemolytic efficiency separated by centrifugation.

Authors:  D W TALMAGE; G G FRETER; W H TALIAFERRO
Journal:  J Infect Dis       Date:  1956 May-Jun       Impact factor: 5.226

3.  Agglutination and mouse protection test of the sera from bacillary dysentery patients.

Authors:  T TAKIGAMI; I TADOKORO
Journal:  Jpn J Exp Med       Date:  1954-06

4.  The separation and analysis of labelled antibodies.

Authors:  D W TALMAGE; H R BAKER; W AKESON
Journal:  J Infect Dis       Date:  1954 Mar-Apr       Impact factor: 5.226

5.  [Blocking antibodies in the serum of brucellosis patients. II. Role in the phenomenon of paradoxal agglutination].

Authors:  G RENOUX
Journal:  Ann Inst Pasteur (Paris)       Date:  1950-08

6.  Studies on Vi antigen. III. Immunological properties of purified Vi antigen derived from Escherichia coli 5396/38.

Authors:  M LANDY; M E WEBSTER
Journal:  J Immunol       Date:  1952-08       Impact factor: 5.422

7.  THE EFFECT OF THE ROUTE OF IMMUNIZATION ON THE IMMUNITY RESPONSE TO PNEUMOCOCCUS TYPE I.

Authors:  E G Stillman
Journal:  J Exp Med       Date:  1930-04-30       Impact factor: 14.307

8.  Coproantibody and bacterial antagonism as protective factors in experimental enteric cholera.

Authors:  R FRETER
Journal:  J Exp Med       Date:  1956-09-01       Impact factor: 14.307

9.  PROPERTIES OF THE TYPE SPECIFIC PROTEINS OF ANTIPNEUMOCOCCUS SERA : I. THE MOUSE PROTECTIVE VALUE OF TYPE I SERA WITH REFERENCE TO THE PRECIPITIN CONTENT.

Authors:  K Goodner; F L Horsfall
Journal:  J Exp Med       Date:  1937-09-30       Impact factor: 14.307

10.  Experimental enteric Shigella and Vibrio infections in mice and guinea pigs.

Authors:  R FRETER
Journal:  J Exp Med       Date:  1956-09-01       Impact factor: 14.307

  10 in total
  6 in total

1.  Studies on the mode of action of the heterologous immunogenicity of a methanol-insoluble fraction of attenuated tubercle bacilli (BCG).

Authors:  C B Steinkuller; L G Krigbaum; D W Weiss
Journal:  Immunology       Date:  1969-02       Impact factor: 7.397

2.  Serotype-converting bacteriophage SfII encodes an acyltransferase protein that mediates 6-O-acetylation of GlcNAc in Shigella flexneri O-antigens, conferring on the host a novel O-antigen epitope.

Authors:  Qiangzheng Sun; Yuriy A Knirel; Jianping Wang; Xia Luo; Sofya N Senchenkova; Ruiting Lan; Alexander S Shashkov; Jianguo Xu
Journal:  J Bacteriol       Date:  2014-08-11       Impact factor: 3.490

3.  Serological identification and prevalence of a novel O-antigen epitope linked to 3- and 4-O-acetylated rhamnose III of lipopolysaccharide in Shigella flexneri.

Authors:  Jianping Wang; Ruiting Lan; Yuriy A Knirel; Xia Luo; Sof'ya N Senchenkova; Alexander S Shashkov; Jianguo Xu; Qiangzheng Sun
Journal:  J Clin Microbiol       Date:  2014-03-26       Impact factor: 5.948

4.  Use of different I 131-labelled antibody eluates in the characterization of Shigella and Vibrio antisera.

Authors:  R FRETER
Journal:  J Exp Med       Date:  1957-06-01       Impact factor: 14.307

5.  Bacteriophages are the major drivers of Shigella flexneri serotype 1c genome plasticity: a complete genome analysis.

Authors:  Pawan Parajuli; Marcin Adamski; Naresh K Verma
Journal:  BMC Genomics       Date:  2017-09-12       Impact factor: 3.969

Review 6.  Immunoglobulin M: An Ancient Antiviral Weapon - Rediscovered.

Authors:  Siqi Gong; Ruth M Ruprecht
Journal:  Front Immunol       Date:  2020-08-11       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.